Feinstein Institute for Medical Research
Grant in 2025
Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior develops a platform that combines wearable devices and machine learning algorithms to monitor key physiological signals such as heart rate and motion. This system, known as Recovery, is designed to support mental health recovery and wellness by delivering timely interventions based on real-time data. By utilizing a software-as-a-service (SaaS) model, Behaivior empowers individuals to maintain their recovery process while enabling care providers to better assist their clients. The integration of AI and behavioral health technology allows Behaivior to recognize patterns in human behavior, ultimately aiming to enhance mental well-being and reduce the incidence of crises, including relapse.
Feinstein Institute for Medical Research
Grant in 2023
Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior develops a platform that combines wearable devices and machine learning algorithms to monitor key physiological signals such as heart rate and motion. This system, known as Recovery, is designed to support mental health recovery and wellness by delivering timely interventions based on real-time data. By utilizing a software-as-a-service (SaaS) model, Behaivior empowers individuals to maintain their recovery process while enabling care providers to better assist their clients. The integration of AI and behavioral health technology allows Behaivior to recognize patterns in human behavior, ultimately aiming to enhance mental well-being and reduce the incidence of crises, including relapse.
Is my medication working? Levl helps you reveal the answer. Levl measures the effectiveness of medications and offers insights to get the most out of mental health treatments. Levl helps people stick to their treatment while supporting clinicians in optimizing the medication.
Feinstein Institute for Medical Research
Grant in 2022
Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Feinstein Institute for Medical Research
Grant in 2022
Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Feinstein Institute for Medical Research
Grant in 2021
Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Feinstein Institute for Medical Research
Grant in 2021
Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Neurotype
Seed Round in 2021
Neurotype is a medical device company dedicated to addressing the challenges of addiction, particularly the environmental triggers that can lead to drug cravings and relapse. Its flagship product, the NeuromarkR platform, consists of a headset and accompanying software that objectively measures brain signatures associated with drug cravings. This innovative technology aims to enhance treatment for individuals recovering from addiction by identifying specific triggers linked to their past drug use. Neurotype's approach incorporates tailored psychotherapy strategies, including Cognitive Behavioral Therapy and Mindfulness-Based Treatment, to provide targeted interventions that help patients manage their cravings more effectively. By focusing on the underlying brain circuits involved in addiction, Neurotype seeks to improve mental and behavioral healthcare for those affected by substance use disorders.
Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior develops a platform that combines wearable devices and machine learning algorithms to monitor key physiological signals such as heart rate and motion. This system, known as Recovery, is designed to support mental health recovery and wellness by delivering timely interventions based on real-time data. By utilizing a software-as-a-service (SaaS) model, Behaivior empowers individuals to maintain their recovery process while enabling care providers to better assist their clients. The integration of AI and behavioral health technology allows Behaivior to recognize patterns in human behavior, ultimately aiming to enhance mental well-being and reduce the incidence of crises, including relapse.
HealthRhythms
Grant in 2017
HealthRhythms is a company that specializes in mental health assessment and treatment through an innovative platform that leverages deep machine learning and predictive analytics. Its solution focuses on real-time, objective monitoring of mental health conditions, providing continuous assessments and personalized digital interventions. By accurately measuring mental health status and anticipating clinical deterioration, HealthRhythms enables healthcare providers to identify and manage patients effectively. The platform enhances the care delivery experience for patients, health plans, payers, and research organizations by offering just-in-time interventions tailored to individual patient profiles. This groundbreaking approach aims to improve overall mental health outcomes and facilitate better management of behavioral health.
Health Behavior Solutions
Grant in 2017
Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.
Health Behavior Solutions
Grant in 2017
Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.
Health Behavior Solutions
Grant in 2016
Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.
Health Behavior Solutions
Grant in 2016
Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.